Skip to content

pre-menstrual acupuncture at sensitized points in the treatment of primary dysmenorrhea:a randomized controlled trail

pre-menstrual acupuncture at sensitized points in the treatment of primary dysmenorrhea:a randomized controlled trail

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072639
Enrollment
Unknown
Registered
2023-06-20
Start date
2023-06-20
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea

Interventions

acupuncture group:acupuncture
Ibuprofen sustained-release capsules can be taken when abdominal pain is unbearable (VAS>=7) in both groups.
blank control group:follow up

Sponsors

Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: A ) The diagnostic criteria were in line with the ' 2017 SOGC clinical practice guidelines : primary dysmenorrhea ( No.345 ) ' and the diagnostic criteria for primary dysmenorrhea in the 9th edition of the textbook ' Obstetrics and Gynecology ' of People 's Health Publishing House ( Xie Xing, Kong Beihua, Duan Tao ) ; tCM syndrome differentiation is based on ' evidence-based acupuncture clinical practice guidelines-primary dysmenorrhea ', which is differentiated as qi stagnation and blood stasis syndrome. b ) 18-30 years of age ; c ) The course of disease was more than 6 menstrual cycles, and the average VAS pain score was = 4 points for 3 consecutive months ; d ) No other treatment was taken or combined within 2 weeks before enrollment ; e ) Regular menstrual cycle, cycle in 28 +- 7 days ; ( f ) To sign the informed consent.

Exclusion criteria

Exclusion criteria: a ) those who had undergone surgery on the trunk, chest and abdomen, and limbs ; b ) local skin ulceration of acupoints ; c ) pregnant, lactating,or postpartum <= 12 months ; d ) with severe primary diseases such as cardiovascular and cerebrovascular, liver, kidney, hematopoietic system, mental illness, etc. ; e ) metal allergy or fear of needles.

Design outcomes

Primary

MeasureTime frame
menstrual pain visual analogue scale score;Incidence of dysmenorrhea;

Secondary

MeasureTime frame
symptom duration and severity measured by the Cox Menstrual Symptom Scale, CMSS;Usage of ibuprofen during menstruation;

Countries

China

Contacts

Public ContactWang Mengqi

Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences

wangmqtcm@163.com+86 130 5115 3867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026